Table 2.
Characteristics of included evaluations for QUOROM, STARD, STRICTA, and STROBE reporting guidelines
| Author, year* | Country of corresponding author | Sources of funding; role of funder; authors’ source(s) of support | Content focus | Specific medical or scientific specialty† | Extent of guideline assessed‡ |
|---|---|---|---|---|---|
| QUOROM, 1999 | |||||
| Hind, 2007128§ | United Kingdom | Not reported; not reported; not reported (authors declare they previously worked for UK NHS Health Technology Assessment Programme (source of included reports)) | Therapeutic interventions (generic) | Unspecified | Subset of items |
| Biondi-Zoccai, 2006129 | Italy | No funding; not applicable; not reported (authors declare no competing interests) | Drug therapies | Urology and nephrology | All items |
| Poolman, 2007130 | Canada, Netherlands | Not reported; not reported; academic: Canadian Institutes of Health Research Canada Research Chair; Industry: Merck Sharp and Dohme Netherlands, Biomet Netherlands, Zimmer Netherlands; other: Stichting Wetenschappelijk Onderzoek Orthopaedische Chirurgie Fellowship, Anna Fonds Foundation, Nederlandse Vereniging voor Orthopedische Traumatologie Fellowship | Surgery | Orthopedics | All items |
| STARD, 2003 | |||||
| Freeman, 2009131§ | United Kingdom | Government agency: European Commission funds allocated to Safe Activities For Everyone Network of Excellence under 6th Framework; not reported; not reported | Biochemical and laboratory research methods | Obstetrics and gynecology | All items |
| Mahoney, 2007132§ | United States | Industry: LifeScan Inc; not reported; study funder | Diagnostic (glucose monitoring) | Endocrinology and metabolism | All items |
| Selman, 2011133§ | United Kingdom | Not reported; not reported; other: charitable foundation (Wellbeing of Women) and Medical Research Council/Royal College of Obstetricians and Gynaecologists Clinical Research Training Fellowship (authors declare no competing interests) | Diagnostic studies | Obstetrics and gynecology | Subset of items¶ |
| Smidt, 2006134§ | Netherlands | Government agency: ZonMW; funder did not play role in study or manuscript**; authors declare no competing interests. | Diagnostic studies | Medicine, general and internal | Subset of items¶ |
| Coppus, 2006135 | Netherlands | Government agency: VIDI-program of ZonMW and charitable foundation: Scientific foundation of the Maxima Medical Center; not reported; not reported |
Diagnostic studies | Reproductive biology | Subset of items§ |
| Johnson, 2007136 | United Kingdom | Not reported; not reported; not reported (authors declare no competing interests) | Diagnostic studies | Ophthalmology | Subset of items |
| Krzych, 2009137 | Poland | Self financed; not applicable; not reported | Diagnostic studies | Cardiac and cardiovascular systems | Subset of items†† |
| Paranjothy, 2007138 | United Kingdom | No funding; not reported; authors state no information to disclose | Diagnostic studies | Ophthalmology | All items |
| STRICTA, 2002‡‡ | |||||
| Hammerschlag, 2011139§ | United States | Not reported; not reported; personnel support from Oregon College of Oriental Medicine research department and Helfgott Research Institute of National College of Natural Medicine | Complementary Medicine | Unspecified | Subset of items¶ |
| STROBE, 2007 | |||||
| Parsons, 2011147§ | United Kingdom | Not reported; not reported; not reported | Surgery | Orthopedics | All items |
| Delaney, 2010140 | United States | Industry: Biomedical Excellence for Safer Transfusion collaborative (industry sponsored); not reported; authors declare no competing interests | Platelet transfusion | Hematology | Subset of items¶ |
*All included evaluations were published as full reports.
†2011 journal impact factor categories used for classification.
‡If authors of evaluations deemed particular guidance item to be “not applicable” to literature they were assessing, those items were excluded from analysis; for evaluations with zero or one studies in one comparison arm, those evaluations were removed from synthesis because that one arm would determine direction of effect.
§Included in quantitative analysis.
¶As determined by authors of this review when comparing with published guidance.
**Specifically, funding agency did not play role in design or conduct of study; collection, management, analysis, or interpretation of data; or preparation, review, or approval of manuscript.
††Authors of evaluations indicated subset was assessed, but authors of this review determined smaller subset was analyzed when comparing with published guidance.
‡‡Unofficial extension of CONSORT reporting guideline.